Compare $HAE vs $SOLV | Chartloom

Compare

$HAE vs $SOLV

Haemonetics Corp · Solventum Corp

HAE

Haemonetics Corp

SOLV

Solventum Corp

Compare $HAE vs $SOLV

Comparing Haemonetics Corp and Solventum Corp

HAEHaemonetics Corp

SOLVSolventum Corp

HAEHaemonetics Corp

Market cap

$5.39B

P/E (TTM)

56.34x

Forward P/E (NTM)

21.33x

Forward P/S (NTM)

3.72x

Rev growth (TTM)

0.4%

YTD performance

48.4%

52W performance

132.8%

FCF yield

4.5%

SOLVSolventum Corp

Market cap

$15.12B

P/E (TTM)

10.55x

Forward P/E (NTM)

12.69x

Forward P/S (NTM)

1.77x

Rev growth (TTM)

-0.9%

YTD performance

10.5%

52W performance

20.5%

FCF yield

-0.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HAE

SOLV

Detailed metrics comparison

HAE

Haemonetics Corp

SOLV

Solventum Corp

Market Cap

HAE$5.39B

SOLV$15.12B

Enterprise Value

HAE$6.35B

SOLV$20.00B

Price

HAE$118.69

SOLV$87.29

P/E Ratio

HAE56.34x

SOLV10.55x

P/S Ratio

HAE3.99x

SOLV1.82x

EV/Sales

HAE4.69x

SOLV2.41x

EV/EBITDA

HAE17.94x

SOLV18.02x

P/B Ratio

HAE5.69x

SOLV3.12x

P/FCF Ratio

HAE22.00x

SOLVN/A

EV/FCF

HAE25.88x

SOLV-172.41x

PEG Ratio

HAEN/A

SOLV0.04x

Forward P/E (NTM)

HAE21.33x

SOLV12.69x

Forward P/S (NTM)

HAE3.72x

SOLV1.77x

Revenue (TTM)

HAE$1.35B

SOLV$8.31B

Revenue Growth (YoY)

HAE0.4%

SOLV-0.9%

Forward Rev Growth

HAE5.2%

SOLV3.5%

Gross Margin (TTM)

HAE59.1%

SOLV54.8%

Operating Margin (TTM)

HAE11.9%

SOLV23.9%

EBITDA Margin (TTM)

HAE26.2%

SOLV13.4%

Net Margin (TTM)

HAE7.1%

SOLV17.3%

FCF Margin (TTM)

HAE18.1%

SOLV-1.4%

Net Income (TTM)

HAE$96M

SOLV$1.43B

FCF (TTM)

HAE$245M

SOLV$-116M

EPS (TTM)

HAE$2.11

SOLV$8.27

ROE (TTM)

HAE11.3%

SOLV29.0%

ROA (TTM)

HAE4.0%

SOLV10.1%

ROIC (TTM)

HAE4.7%

SOLV14.2%

Cash

HAE$223M

SOLV$403M

Debt

HAE$1.17B

SOLV$5.29B

Net Cash/Debt

HAE$-951M

SOLV$-4.88B

Current Ratio (TTM)

HAE3.08x

SOLV1.02x

Quick Ratio (TTM)

HAE1.67x

SOLV0.70x

Debt/Equity (TTM)

HAE1.40x

SOLV1.10x

Debt/Assets (TTM)

HAE0.0%

SOLV0.0%

Interest Coverage (TTM)

HAEN/A

SOLVN/A

Net Debt/EBITDA (TTM)

HAE0.00x

SOLV0.00x

Beta

HAE0.62

SOLV0.74

52W Performance

HAE132.8%

SOLV20.5%

YTD Performance

HAE48.4%

SOLV10.5%

% from 52W High

HAE-2.1%

SOLV-7.3%

% from 52W Low

HAE146.4%

SOLV39.9%

Asset Turnover (TTM)

HAE0.56x

SOLV0.59x

FCF Yield (TTM)

HAE4.5%

SOLV-0.8%

Earnings Yield (TTM)

HAE1.8%

SOLV9.5%

Dividend Yield (TTM)

HAEN/A

SOLVN/A

Rule of 40

HAE18.6

SOLV-2.3

EV/GP/RG

HAE1.08

SOLV1.58

Ticker research

View HAE research View SOLV research

Metric	HAE Haemonetics Corp	SOLV Solventum Corp
Market & Valuation
Market Cap	$5.39B	$15.12B
Enterprise Value	$6.35B	$20.00B
Price	$118.69	$87.29
P/E Ratio	56.34x	10.55x
P/S Ratio	3.99x	1.82x
EV/Sales	4.69x	2.41x
EV/EBITDA	17.94x	18.02x
P/B Ratio	5.69x	3.12x
P/FCF Ratio	22.00x	N/A
EV/FCF	25.88x	-172.41x
PEG Ratio	N/A	0.04x
Forward P/E (NTM)	21.33x	12.69x
Forward P/S (NTM)	3.72x	1.77x
Revenue & Growth
Revenue (TTM)	$1.35B	$8.31B
Revenue Growth (YoY)	0.4%	-0.9%
Forward Rev Growth	5.2%	3.5%
Profitability
Gross Margin (TTM)	59.1%	54.8%
Operating Margin (TTM)	11.9%	23.9%
EBITDA Margin (TTM)	26.2%	13.4%
Net Margin (TTM)	7.1%	17.3%
FCF Margin (TTM)	18.1%	-1.4%
Net Income (TTM)	$96M	$1.43B
FCF (TTM)	$245M	$-116M
EPS (TTM)	$2.11	$8.27
ROE (TTM)	11.3%	29.0%
ROA (TTM)	4.0%	10.1%
ROIC (TTM)	4.7%	14.2%
Financial Health
Cash	$223M	$403M
Debt	$1.17B	$5.29B
Net Cash/Debt	$-951M	$-4.88B
Current Ratio (TTM)	3.08x	1.02x
Quick Ratio (TTM)	1.67x	0.70x
Debt/Equity (TTM)	1.40x	1.10x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	0.74
52W Performance	132.8%	20.5%
YTD Performance	48.4%	10.5%
% from 52W High	-2.1%	-7.3%
% from 52W Low	146.4%	39.9%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.59x
FCF Yield (TTM)	4.5%	-0.8%
Earnings Yield (TTM)	1.8%	9.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	18.6	-2.3
EV/GP/RG	1.08	1.58
Ticker research	View HAE research	View SOLV research

Valuation

P/E Ratio

SOLV

10.55x

HAE

56.34x

P/S Ratio

SOLV

1.82x

HAE

3.99x

EV/FCF

SOLV

-172.41x

HAE

25.88x

Growth & revenue

Revenue Growth TTM

HAE

0.4%

SOLV

-0.9%

Forward Revenue Growth

HAE

5.2%

SOLV

3.5%

Profitability & performance

Gross Margin

HAE

59.1%

SOLV

54.8%

ROE

SOLV

29.0%

HAE

11.3%

FCF Yield %

HAE

4.5%

SOLV

-0.8%

52-Week Performance

HAE

132.8%

SOLV

20.5%

Detailed metrics comparison

HAE

Haemonetics Corp

SOLV

Solventum Corp

Market Cap

HAE$5.39B

SOLV$15.12B

Enterprise Value

HAE$6.35B

SOLV$20.00B

Price

HAE$118.69

SOLV$87.29

P/E Ratio

HAE56.34x

SOLV10.55x

P/S Ratio

HAE3.99x

SOLV1.82x

EV/Sales

HAE4.69x

SOLV2.41x

EV/EBITDA

HAE17.94x

SOLV18.02x

P/B Ratio

HAE5.69x

SOLV3.12x

P/FCF Ratio

HAE22.00x

SOLVN/A

EV/FCF

HAE25.88x

SOLV-172.41x

PEG Ratio

HAEN/A

SOLV0.04x

Forward P/E (NTM)

HAE21.33x

SOLV12.69x

Forward P/S (NTM)

HAE3.72x

SOLV1.77x

Revenue (TTM)

HAE$1.35B

SOLV$8.31B

Revenue Growth (YoY)

HAE0.4%

SOLV-0.9%

Forward Rev Growth

HAE5.2%

SOLV3.5%

Gross Margin (TTM)

HAE59.1%

SOLV54.8%

Operating Margin (TTM)

HAE11.9%

SOLV23.9%

EBITDA Margin (TTM)

HAE26.2%

SOLV13.4%

Net Margin (TTM)

HAE7.1%

SOLV17.3%

FCF Margin (TTM)

HAE18.1%

SOLV-1.4%

Net Income (TTM)

HAE$96M

SOLV$1.43B

FCF (TTM)

HAE$245M

SOLV$-116M

EPS (TTM)

HAE$2.11

SOLV$8.27

ROE (TTM)

HAE11.3%

SOLV29.0%

ROA (TTM)

HAE4.0%

SOLV10.1%

ROIC (TTM)

HAE4.7%

SOLV14.2%

Cash

HAE$223M

SOLV$403M

Debt

HAE$1.17B

SOLV$5.29B

Net Cash/Debt

HAE$-951M

SOLV$-4.88B

Current Ratio (TTM)

HAE3.08x

SOLV1.02x

Quick Ratio (TTM)

HAE1.67x

SOLV0.70x

Debt/Equity (TTM)

HAE1.40x

SOLV1.10x

Debt/Assets (TTM)

HAE0.0%

SOLV0.0%

Interest Coverage (TTM)

HAEN/A

SOLVN/A

Net Debt/EBITDA (TTM)

HAE0.00x

SOLV0.00x

Beta

HAE0.62

SOLV0.74

52W Performance

HAE132.8%

SOLV20.5%

YTD Performance

HAE48.4%

SOLV10.5%

% from 52W High

HAE-2.1%

SOLV-7.3%

% from 52W Low

HAE146.4%

SOLV39.9%

Asset Turnover (TTM)

HAE0.56x

SOLV0.59x

FCF Yield (TTM)

HAE4.5%

SOLV-0.8%

Earnings Yield (TTM)

HAE1.8%

SOLV9.5%

Dividend Yield (TTM)

HAEN/A

SOLVN/A

Rule of 40

HAE18.6

SOLV-2.3

EV/GP/RG

HAE1.08

SOLV1.58

Ticker research

View HAE research View SOLV research

Metric	HAE Haemonetics Corp	SOLV Solventum Corp
Market & Valuation
Market Cap	$5.39B	$15.12B
Enterprise Value	$6.35B	$20.00B
Price	$118.69	$87.29
P/E Ratio	56.34x	10.55x
P/S Ratio	3.99x	1.82x
EV/Sales	4.69x	2.41x
EV/EBITDA	17.94x	18.02x
P/B Ratio	5.69x	3.12x
P/FCF Ratio	22.00x	N/A
EV/FCF	25.88x	-172.41x
PEG Ratio	N/A	0.04x
Forward P/E (NTM)	21.33x	12.69x
Forward P/S (NTM)	3.72x	1.77x
Revenue & Growth
Revenue (TTM)	$1.35B	$8.31B
Revenue Growth (YoY)	0.4%	-0.9%
Forward Rev Growth	5.2%	3.5%
Profitability
Gross Margin (TTM)	59.1%	54.8%
Operating Margin (TTM)	11.9%	23.9%
EBITDA Margin (TTM)	26.2%	13.4%
Net Margin (TTM)	7.1%	17.3%
FCF Margin (TTM)	18.1%	-1.4%
Net Income (TTM)	$96M	$1.43B
FCF (TTM)	$245M	$-116M
EPS (TTM)	$2.11	$8.27
ROE (TTM)	11.3%	29.0%
ROA (TTM)	4.0%	10.1%
ROIC (TTM)	4.7%	14.2%
Financial Health
Cash	$223M	$403M
Debt	$1.17B	$5.29B
Net Cash/Debt	$-951M	$-4.88B
Current Ratio (TTM)	3.08x	1.02x
Quick Ratio (TTM)	1.67x	0.70x
Debt/Equity (TTM)	1.40x	1.10x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	0.74
52W Performance	132.8%	20.5%
YTD Performance	48.4%	10.5%
% from 52W High	-2.1%	-7.3%
% from 52W Low	146.4%	39.9%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.59x
FCF Yield (TTM)	4.5%	-0.8%
Earnings Yield (TTM)	1.8%	9.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	18.6	-2.3
EV/GP/RG	1.08	1.58
Ticker research	View HAE research	View SOLV research